학술논문
Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study
Document Type
Article
Author
Source
In ESMO Open October 2021 6(5)
Subject
Language
ISSN
2059-7029